Siemens, U-Systems to partner on breast US

AuntMinnie.com staff writers

Feb 4, 2004

Multimodality vendor Siemens Medical Solutions of Malvern, PA, and full-field breast ultrasound (FFBU) developer U-Systems of Sunnyvale, CA, have entered into a partnership agreement.

Under terms of the deal, Siemens will provide the ultrasound engine of its Sonoline Antares ultrasound system for integration into U-Systems’ FFBU system. The combination of the Siemens’ beamformer integrated with U-Systems’ transducer and image display will produce standardized ultrasound images that can easily be correlated to mammography exams, Siemens said.

By AuntMinnie.com staff writers
February 5, 2004
Related Reading

Large echo order for Siemens, January 30, 2004

Siemens gets MGH install, January 27, 2004

Siemens profit up in Q1, January 26, 2004

Premier launches group buy of Siemens CT, January 22, 2004

New financing for U-Systems, December 22, 2003

Copyright © 2004 AuntMinnie.com

Ultrasound-guided nerve blocks safe for emergency pain management

November 13, 2024

Thermal ablation effective long term in patients with thyroid cancer

November 7, 2024

Could cranial ultrasound sub for brain MRI in imaging infants?

November 6, 2024

Images depict a 43-year-old woman with a malignant nonmass lesion that was diagnosed as microinvasive ductal carcinoma. (A) Transverse and (B) longitudinal ultrasound images show a hypoechoic nonmass lesion (solid arrows) with segmental distribution in the left breast. The lesion has associated calcifications (dashed arrows in A). (C) Longitudinal color Doppler ultrasound image shows high vascularity. (D) Magnified image in the mediolateral oblique view from screening mammography shows grouped calcifications (arrows), which are considered a mammographic correlate of the ultrasound-detected nonmass lesion (A radiopaque marker attached to the skin is visible in the image because the mammographic exam was performed after screening breast ultrasound). Ultrasound-guided core needle biopsy and pathologic examination revealed ductal carcinoma in situ, but the lesion was upgraded to microinvasive ductal carcinoma at subsequent surgery (2.5-cm ductal carcinoma in situ, histologic grade II, estrogen receptor-positive, progesterone receptor-positive, human epidermal growth factor receptor type 2-negative).

Ultrasound nonmass breast lesion features may signal malignancy

November 5, 2024

Ultrasound-guided nerve blocks safe for emergency pain management

By Amerigo Allegretto

Ultrasound-guided nerve blocks (UGNBs) performed by emergency clinicians could be safe for pain management.

November 13, 2024

Thermal ablation effective long term in patients with thyroid cancer

Outcomes over 10 years suggest that image-guided thermal ablation is a safe and effective option for patients with papillary thyroid carcinoma.

November 7, 2024

Could cranial ultrasound sub for brain MRI in imaging infants?

By Amerigo Allegretto

Cranial ultrasound could have utility for imaging infants with hypoxic-ischemic encephalopathy.

November 6, 2024

Ultrasound nonmass breast lesion features may signal malignancy

By Amerigo Allegretto

Some nonmass breast lesion characteristics on ultrasound exams can be considered suspicious for malignancy at screening ultrasound.

November 5, 2024

Images depict a 43-year-old woman with a malignant nonmass lesion that was diagnosed as microinvasive ductal carcinoma. (A) Transverse and (B) longitudinal ultrasound images show a hypoechoic nonmass lesion (solid arrows) with segmental distribution in the left breast. The lesion has associated calcifications (dashed arrows in A). (C) Longitudinal color Doppler ultrasound image shows high vascularity. (D) Magnified image in the mediolateral oblique view from screening mammography shows grouped calcifications (arrows), which are considered a mammographic correlate of the ultrasound-detected nonmass lesion (A radiopaque marker attached to the skin is visible in the image because the mammographic exam was performed after screening breast ultrasound). Ultrasound-guided core needle biopsy and pathologic examination revealed ductal carcinoma in situ, but the lesion was upgraded to microinvasive ductal carcinoma at subsequent surgery (2.5-cm ductal carcinoma in situ, histologic grade II, estrogen receptor-positive, progesterone receptor-positive, human epidermal growth factor receptor type 2-negative).

ChatGPT demonstrates mixed results in assigning BI-RADS categories

By Amerigo Allegretto

ChatGPT achieves modest accuracy when assigning BI-RADS scores for mammograms and breast ultrasound exams.

November 1, 2024

ABUS screening improves breast cancer screening in low-resource areas

By Amerigo Allegretto

Automated breast ultrasound (ABUS) with remote reading may improve access to breast cancer screening and early detection in low-resource settings.

October 29, 2024

Ultrasound Breast 400

Ukraine's top pediatric hospital rebuilds after bomb attack

Radiology staff at the Ohmatdyt Children's Hospital in Kyiv are making steady progress with their plan to restore normal service after a devastating missile attack.

October 25, 2024

Thanks to the support of the global imaging community, radiology staff at the Ohmatdyt can now look forward to restoring normal service.

CNN models using ultrasound images detect pancreatic neoplasms

By Amerigo Allegretto

A deep-learning method using endoscopic ultrasound images could detect pancreatic neuroendocrine neoplasms.

October 18, 2024

Ultrasound Scanner Computerized 400

Ultrasound method detects cellular rejection in liver transplant cases

By Amerigo Allegretto

An ultrasound measurement technique could detect and stage acute cellular rejection in liver transplant patients.

October 16, 2024

Ultrasound Diagnostic Control Panel

Could elastography replace conventional ultrasound-guided FNAC?

By Amerigo Allegretto

Strain elastography does not have additional benefits over conventional elastography-guided FNAC for diagnosing malignancy in thyroid nodules.

October 15, 2024

Images depict a 43-year-old woman with a solitary left-sided thyroid nodule classified at gray-scale ultrasound as category U3, upgraded to category U4 at strain elastography, and classified as category Thy4 at cytopathologic examination. Subsequent surgical histopathologic examination confirmed papillary cell carcinoma. (A) Longitudinal view of the left thyroid lobe demonstrates the low reflective nodule (between arrows) measuring 13 × 12 × 11 mm (not shown) and with a halo. (B) A longitudinal image with side-by-side visualization of the nodule (arrow) at gray scale (left) and strain elastography (right). The nodule is predominantly blue, indicating increased stiffness. (C) A longitudinal view shows the needle (arrows) within the stiffer aspect of the nodule for cytology sampling. U and Thy categories are according to British Thyroid Association system. Image courtesy of the RSNA.

Ultrasound test detects 96% of ovarian cancers

By Kate Madden Yee

An ultrasound test can identify 96% of ovarian cancers in postmenopausal women, researchers have reported.

October 1, 2024

Publicly insured pregnant women less likely to get 20-week ultrasounds

By Amerigo Allegretto

Twenty-week ultrasound exams for pregnant women drives disparities in prenatal diagnosis of congenital heart defects.

September 23, 2024

Fetal Ultrasound

Page 1 of 512